Page last updated: 2024-11-04

terbutaline and Inflammatory Bowel Diseases

terbutaline has been researched along with Inflammatory Bowel Diseases in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research Excerpts

ExcerptRelevanceReference
"We analyzed the in vitro effects of the beta-adrenergic agonist terbutaline and the glucocorticoid agonist dexamethasone on TNF-alpha and IL-10 production by LPS-stimulated monocytes in whole cell blood cultures in patients with inflammatory bowel diseases in remission (N=10), diarrhoea-predominant irritable bowel syndrome (IBS, N=12), patients with a recent gastroenteritis (post-infectious group, N=10), and healthy controls (N=15)."3.74Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission. ( Cobelens, PM; Dobos, GJ; Elsenbruch, S; Gerken, G; Haag, S; Heijnen, CJ; Holtmann, G; Kavelaars, A; Langhorst, J; Lucas, A; Schedlowski, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lucas, A1
Cobelens, PM1
Kavelaars, A1
Heijnen, CJ1
Holtmann, G1
Haag, S1
Gerken, G1
Langhorst, J1
Dobos, GJ1
Schedlowski, M1
Elsenbruch, S1

Other Studies

1 other study available for terbutaline and Inflammatory Bowel Diseases

ArticleYear
Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission.
    Journal of neuroimmunology, 2007, Volume: 182, Issue:1-2

    Topics: Adrenergic beta-Agonists; Adult; Dexamethasone; Diarrhea; Dose-Response Relationship, Drug; Gastroen

2007